1 / 38

Seeing Beyond Age in the Management of Advanced Lung Cancer

Seeing Beyond Age in the Management of Advanced Lung Cancer. Patient Case 1: Presentation. Patient Case 1: Diagnosis. IFCT-0501 Trial of Platinum-Doublet vs Single Agent Chemo for Advanced NSCLC in Patients Age 70-89 Years. IFCT-0501 Trial: OS. nab -Paclitaxel in Patients Older Than 70 Years.

gretchen-torres
Download Presentation

Seeing Beyond Age in the Management of Advanced Lung Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Seeing Beyond Age in the Management of Advanced Lung Cancer

  2. Patient Case 1: Presentation

  3. Patient Case 1: Diagnosis

  4. IFCT-0501 Trial of Platinum-Doublet vs Single Agent Chemo for Advanced NSCLC in Patients Age 70-89 Years

  5. IFCT-0501 Trial: OS

  6. nab-Paclitaxel in Patients Older Than 70 Years

  7. Phase III Randomized Trial of Pemetrexed vs Carboplatin and Pemetrexed in Patients With Advanced NSCLC and PS of 2

  8. OS

  9. Bevacizumab in Older Patients: SEER Data

  10. PointBreak: Study Design

  11. PointBreak: KM OS From Randomization (ITT)

  12. PointBreak: CTCAEs (Version 3) Possibly Related to a Study Drug (Safety Population)

  13. Patient 1: First-line Treatment and Follow-up

  14. AVAPERL 1 Study Design

  15. AVAPERL: PFS Subgroup

  16. PointBreak: Pre-specified Exploratory Analysis of KM OS from Randomization: Maintenance Group

  17. PARAMOUNT: Final OS From Randomization

  18. PARAMOUNT: OS Subgroups

  19. Patient Case 2: Initial Presentation

  20. Patient Case 2: Oncology Clinic

  21. Patient Case 2: Restaging

  22. Gemcitabine and Erlotinib in the Elderly: First-line (All Comers)

  23. TOPICAL Study Design

  24. TOPICAL

  25. TOPICAL

  26. BATTLE and Older Patients

  27. Genotype and Age

  28. Erlotinib in the Elderly

  29. Afatinib in the Elderly

  30. Patient Case 2: Treatment Plans

  31. Patient Case 2: Follow-up

  32. Abbreviations

  33. Abbreviations (cont)

  34. Abbreviations (cont)

  35. Abbreviations (cont)

  36. References

  37. References (cont)

  38. References (cont)

More Related